Skip to main content
Fig. 2 | Molecular Medicine

Fig. 2

From: Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients

Fig. 2

Overall survival (OS) and disease-free survival (DFS) of triple-negative breast cancer patients in the sub-group of patients displaying positive KLK12 mRNA expression in primary tumor tissues. Patients with elevated KLK12 mRNA expression levels display a significantly worse OS (a Kaplan-Meier analysis, p = 0.037) and DFS (bp = 0.041), respectively, compared to patients with low KLK12 mRNA expression levels

Back to article page

Molecular Medicine

ISSN: 1528-3658